tradingkey.logo


tradingkey.logo


Haleon PLC

HLN
9.740USD
+0.040+0.41%
āļ›āļīāļ” 03/25, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
44.09BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
35.35P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Haleon PLC āļšāļĢāļīāļĐāļąāļ—

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

āļ‚āđ‰āļ­āļĄāļđāļĨ Haleon PLC


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™HLN
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Haleon PLC
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļJul 18, 2022
āļ‹āļĩāļ­āļĩāđ‚āļ­Mcnamara (Brian)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™- -
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒDepository Receipt
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Jul 18
āļ—āļĩāđˆāļ­āļĒāļđāđˆBuilding 5, First Floor
āđ€āļĄāļ·āļ­āļ‡WEYBRIDGE
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited Kingdom
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒKT13 0NY
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ441932822000
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.haleon.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™HLN
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļJul 18, 2022
āļ‹āļĩāļ­āļĩāđ‚āļ­Mcnamara (Brian)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Haleon PLC


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dame Vivienne Cox
Dame Vivienne Cox
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Asmita Dubey
Ms. Asmita Dubey
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Amanda J. Mellor
Ms. Amanda J. Mellor
Company Secretary
Company Secretary
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
EMEA and LatAm
1.12B
42.67%
Northern America
871.00M
33.16%
APAC
635.00M
24.17%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 20 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 20 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Dodge & Cox
3.40%
Fidelity Management & Research Company LLC
2.06%
ClearBridge Investments, LLC
0.70%
Harding Loevner LP
0.37%
Norges Bank Investment Management (NBIM)
0.36%
āļ­āļ·āđˆāļ™ āđ†
93.10%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Dodge & Cox
3.40%
Fidelity Management & Research Company LLC
2.06%
ClearBridge Investments, LLC
0.70%
Harding Loevner LP
0.37%
Norges Bank Investment Management (NBIM)
0.36%
āļ­āļ·āđˆāļ™ āđ†
93.10%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
5.32%
Investment Advisor/Hedge Fund
5.30%
Research Firm
0.86%
Hedge Fund
0.64%
Sovereign Wealth Fund
0.36%
Bank and Trust
0.17%
Family Office
0.06%
Family Office
0.06%
Family Office
0.06%
āļ­āļ·āđˆāļ™ āđ†
87.17%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
1068
546.97M
12.28%
-32.09M
2025Q3
1049
570.14M
12.80%
-16.29M
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
2023Q3
933
688.70M
14.92%
-37.88M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
Dodge & Cox
154.38M
3.47%
-1.09M
-0.70%
Sep 30, 2025
Fidelity Management & Research Company LLC
89.11M
2%
-8.41M
-8.62%
Sep 30, 2025
ClearBridge Investments, LLC
33.35M
0.75%
+1.90M
+6.05%
Sep 30, 2025
Harding Loevner LP
17.91M
0.4%
-4.64M
-20.58%
Sep 30, 2025
Fidelity Institutional Asset Management
14.89M
0.33%
+651.50K
+4.58%
Sep 30, 2025
Sculptor Capital Management, Inc
9.95M
0.22%
--
--
Sep 30, 2025
Morgan Stanley Smith Barney LLC
7.70M
0.17%
+1.34M
+21.15%
Sep 30, 2025
Parametric Portfolio Associates LLC
7.56M
0.17%
-635.76K
-7.76%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
VanEck Pharmaceutical ETF
6.34%
Franklin ClearBridge Enhanced Income ETF
1.87%
One Global ETF
0.65%
ActivePassive International Equity ETF
0.33%
SP Funds S&P World (ex-US) ETF
0.27%
Avantis Responsible International Equity ETF
0.13%
Avantis International Equity ETF
0.08%
Avantis International Large Cap Value ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
Fidelity Blue Chip Value ETF
0%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
VanEck Pharmaceutical ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™6.34%
Franklin ClearBridge Enhanced Income ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.87%
One Global ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.65%
ActivePassive International Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.33%
SP Funds S&P World (ex-US) ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.27%
Avantis Responsible International Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.13%
Avantis International Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.08%
Avantis International Large Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
Unusual Whales Subversive Democratic Trading ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
Fidelity Blue Chip Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 570.00M USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Feb 26, 2026
HLN.NB Approximate final Cash Dividend of gross USD 0.130732 paid on May 14, 2026 going ex on Apr 10, 2026
Apr 10, 2026
May 14, 2026
Apr 10, 2026
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™